<DOC>
	<DOCNO>NCT02585401</DOCNO>
	<brief_summary>The primary objective study measure physician knowledge understand key safety information contain Eylea vial preparation instruction card , intravitreal injection procedure video , product monograph .</brief_summary>
	<brief_title>Evaluation Physician Knowledge Safety Safe Use Information Aflibercept Canada</brief_title>
	<detailed_description>The source information study self-reported data collect physician use standard questionnaire closed-ended response choice . Questionnaires physicians develop test use best practice instrument development . The question tailor study aim information provide vial preparation instruction card , intravitreal injection procedure video , Eylea product monograph . Other question obtain information need assess potential difference across subgroup identify bias ( e.g. , demographic , experience Eylea ) . The questionnaire test cognitive interview physician . Questionnaires test local language , assure introductory material , consent form , questionnaire item ( question stem response choice ) culturally appropriate easily correctly understood individual similar participate</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<criteria>This study conduct retinal specialist ophthalmologists Canada prescribe and/or administer aflibercept least 1 patient past 6 month . None apply</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>